Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

P21 Dosage Guide, Benefits & Side Effects

P21 Dosage Guide, Benefits & Side Effects P21 crosses the blood-brain barrier to spur hippocampal neurogenesis and slow amyloid pathology, extending survival in Alzheimer's models. Chemical Makeup 4 Amino Acids P21 Asp Position 1 Gly Position 2 Position 3 Leu

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

P21 Dosage Guide, Benefits & Side Effects

P21 crosses the blood-brain barrier to spur hippocampal neurogenesis and slow amyloid pathology, extending survival in Alzheimer's models.

Chemical Makeup

4

Amino Acids

P21

Asp

Position 1

Gly

Position 2

Position 3

Leu

Position 4

As seen on

P21 Dosage Guide for Cognitive EnhancementP21 Dosage Calculator

P21 is a lab-made peptide that may help brain cells grow and support memory, without the side effects of the natural hormone it's based on. People usually take it as a nasal spray or a small injection under the skin.

Vial size

5 mg

Bacteriostatic water

2 mL

Dosing

50–100 mcg

Frequency

Daily

Cycle

20 consecutive days

Benefit

Cognitive Enhancement

What is P21?

P21 is a lab-made peptide, based on a small piece of a natural brain-growth signal, chemically modified so it can cross into the brain more easily and last longer. It works by boosting a brain-growth protein (BDNF) and blocking a signal that normally suppresses the growth of new brain cells. It's studied mainly in early research related to Alzheimer's disease and age-related memory decline.

Cognitive

Research targets include neural signaling, memory formation, and mental clarity pathways.

Longevity

Research targets include cellular aging, senescence, and long-term healthspan.

p21

Is P21 FDA approved?

P21 is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

P21 has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

Our top-rated vendor

View all vendors

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health

#1 Rated Research Peptide Supplier

How Does P21 Work?

It blocks a signal that would normally keep brain stem cells from multiplying, while also boosting a brain-growth protein (BDNF) that helps neurons survive and adapt. Together, these effects encourage new brain cell growth, help protect against a protein buildup linked to memory problems, and support stronger connections between brain cells.

Removes a brake

Blocks a signal that normally limits brain stem cell growth.

Raises BDNF

Boosts a brain-growth protein that helps neurons survive and adapt.

Strengthens connections

Encourages new brain cell growth and stronger connections between neurons.

P21 Targeted areas

How to reconstitute P21

The materials you'll need and step-by-step instructions for safely mixing P21 with bacteriostatic water.

Materials needed

Your P21 vial (lyophilized)

Alcohol swabs

Bacteriostatic sterile water

3 mL syringes (Luer Lock tip)

25G or 27G needles (Luer Lock). Other gauges may also be acceptable.

Sharps container (optional)

Remove the caps

Sanitize the rubber stoppers

Attach the needle

Draw the bac water

Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.

Insert the needle into the P21 vial

With the bac water in your syringe, insert the needle into the P21 vial at a slight angle to avoid pressure buildup.

Release the water gently

Let the water run gently down the side of the vial. Don't inject it forcefully.

Swirl to dissolve

Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.

Check for full dissolution

Cap, dispose, and store

How to Store P21

Freeze the dry powder for 12–24 months. Once mixed with bacteriostatic water, refrigerate and use within about a month, protected from light.

Lyophilized Storage

-20°C, stable 12–24 months.

Reconstituted Storage

In bacteriostatic water, 2–8°C for up to 28 days.

Handling Notes

Protect from light.

What Are the Benefits of P21?

What research says it may help with, and how it works in the body.

neurodegenerative disease

If given during the brain's early window of trying to compensate for damage to connections between nerve cells, treatment can stop further brain cell loss and lower the risk of death.

Strongly reduces harmful tau protein buildup by boosting a chain of natural brain-growth signals that support nerve cell health and survival.

In mice bred to develop an Alzheimer's-like disease, P021 significantly cut down two of the harmful protein buildups linked to the condition (tangled tau protein and amyloid-beta plaques) and restored memory for personal events and experiences that had been impaired.

cognitive enhancement

Boosts the growth of new brain cells in a memory-related brain region (the dentate gyrus) so strongly that treated brains actually produce more new cells than healthy, untreated brains do.

May slow the normal age-related drop in learning and memory by reversing the age-related slowdown in new brain cell growth.

Improves memory by raising levels of a natural growth factor for brain cells and by restoring healthy communication between nerve cells.

neuroprotection

Repairs weakened connections between nerve cells in two key brain regions involved in thinking and memory (the cortex and hippocampus).

Restores the brain's natural ability to adapt and strengthen connections between nerve cells, a process needed for learning.

What Are the Side Effects of P21?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Not approved for human use

Pregnancy or breastfeeding

Unknown safety profile in humans

Stop Right Away If You Notice

Allergic reactions

Unusual neurological symptoms

Milder Signs to Watch For

How Long Should a P21 Cycle Last?

This breaks down how long a typical P21 cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Related peptides

pin

Pinealon

Preclinical

sel

Selank

Approved

sema

Semax

Healing

ara

Ara 290

Phase 2

Cheat Sheets Featuring P21

See how P21 fits into a broader research stack with these free downloadable cheat sheets. Each one includes reference dose ranges, dosing frequency, and half-life for every peptide it covers. For research purposes only.

16 peptides

42 peptides

78 peptides

P21 Research References

It is a preclinical compound

P21 is a preclinical compound

P021 markedly reduced tau pathology, attenuated Aβ, rescued episodic memory, and reduced mortality in AD mice.

n.d.

May reduce age-related cognitive decline by restoring BDNF expression and synaptic function.

Beneficial effects in preclinical studies make P21 highly promising for AD drug development.

Disease-modifying effect via BDNF/TrkB/PI3-K/AKT/GSK3β pathway; rescued neurogenesis and cognition.

Frequently Asked Questions About P21

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

What is P21 and how does it work?

P21 (sometimes called P021 or 'Adamax') is a small synthetic tetrapeptide designed to mimic the most active region (residues 148-151) of ciliary neurotrophic factor (CNTF), a naturally occurring neurotrophic protein. Natural CNTF is too large and unstable to cross the blood-brain barrier and can trigger antibody formation when given systemically, so researchers attached an adamantylated glycine group to the peptide fragment to increase its lipophilicity, blood-brain barrier penetration, and resistance to enzymatic breakdown. In preclinical studies, P21 is reported to activate CNTF-related signaling pathways involved in neuron survival and plasticity.

What is P21 being researched for?

Most published and vendor-cited research on P21 focuses on neurodegeneration and cognition models: increasing BDNF (brain-derived neurotrophic factor) expression, promoting hippocampal neurogenesis and synaptic plasticity, and reducing markers associated with Alzheimer's disease pathology such as amyloid-beta plaque buildup and abnormal tau phosphorylation (via effects on GSK-3β activity). It has also been studied in models of age-related macular degeneration and appetite/metabolic regulation, since CNTF signaling touches both neural and metabolic pathways. These findings come from animal and cell-culture studies; there are no completed controlled human clinical trials establishing efficacy for any of these uses.

What dosages are commonly discussed in research protocols?

Dosing conventions vary widely across vendor and community sources, which is a sign there is no single validated human protocol. Commonly cited research ranges include roughly 100-500 mcg per day by subcutaneous injection over 4-6 weeks, or 500 mcg-1 mg per day intranasally (with some sources referencing higher 1-5 mg intranasal or subcutaneous ranges used in 2-4 week cycles). Given this inconsistency and the lack of human trial data, any specific number should be treated as anecdotal rather than an established or medically endorsed dose.

How is P21 typically administered and reconstituted?

In research contexts, P21 is most often used as an intranasal spray or, less commonly, as a subcutaneous injection, since intranasal delivery is frequently described as the preferred non-invasive route for CNS-directed peptides. Lyophilized (freeze-dried) P21 is reconstituted with bacteriostatic or sterile water, added slowly against the vial wall and gently swirled (not shaken) until the solution is clear with no visible particles.

How should P21 be stored, and how long does it last after mixing?

Unreconstituted, lyophilized P21 is generally kept frozen at about -20°C and protected from light (e.g., wrapped in foil or kept in an opaque container), which sources report can preserve it with minimal degradation for an extended period. Once reconstituted, it should be refrigerated at roughly 2-8°C and used within about 2-4 weeks; solutions mixed with bacteriostatic water (which contains a preservative) are generally considered stable longer than those mixed with plain sterile water.

What side effects are reported with P21?

Preclinical animal studies, including up to 12 months of continuous dosing in mice, have reported a favorable safety profile with no major adverse effects observed at study doses. However, this data comes from animal models, not controlled human trials, so the real-world side-effect profile in humans is not well established. As with any nootropic-type compound, sources note a theoretical risk of psychological (not physical) dependence tied to perceived cognitive benefits rather than the peptide itself.

What is P21 commonly stacked with?

The most frequently discussed combination is P21 with Semax. The rationale given is that the two peptides raise BDNF through different upstream mechanisms (P21 via CNTF/LIF-related signaling, Semax via the ACTH/melanocortin pathway), so proponents describe them as complementary rather than redundant. As with dosing, stacking protocols are drawn from community and vendor sources rather than controlled trials.

Is P21 legal, and is it approved for human use?

P21 is sold in the United States and elsewhere as a research chemical for laboratory/research use only, not as an approved drug or supplement. It is not FDA-approved for human use, has no established prescribing pathway, and has not completed controlled human clinical trials. Purchasing and possessing it for research purposes is generally legal in the U.S., but using it on oneself falls outside any regulated or medically supervised framework, and product quality (purity, sterility, accurate labeling) varies by supplier since these products are not regulated the way pharmaceuticals are.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Research Indications

P021 markedly reduced tau pathology, attenuated Aβ generation, and rescued episodic memory impairment in 3xTg-AD mice. Treatment during synaptic compensation period can prevent neurodegeneration and reduce mortality. Robust attenuation of tau pathologies through BDNF/TrkB/PI3-K/AKT/GSK3β pathway. Enhances dentate gyrus neurogenesis so effectively it exceeds levels in healthy untreated brains. Enhances memory processes through increased BDNF and restored synaptic function. May reduce natural decline in learning and memory in aged models by rescuing neurogenesis deficit. Restores synaptic deficits in cortex and hippocampus. Rescues deficits in neuronal plasticity.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Potential benefits

Primary Benefits

P21 is a purpose-built neurotrophic compound that enhances learning, short-term memory, and spatial reference memory in normal mice while demonstrating disease-modifying cognitive rescue in Alzheimer's disease mouse models through BDNF-mediated neurogenesis and synaptic plasticity enhancement. By promoting adult hippocampal neurogenesis and reversing age-related synaptic deficits, P21 addresses the structural basis of cognitive aging. Long-term studies (up to 12 months in mice) show sustained neurogenic and neuroprotective effects without the adverse effects of the parent molecule CNTF. P21's BDNF-enhancing and neurogenesis-promoting properties have demonstrated neuroprotective effects in models of traumatic brain injury and neurodegenerative disease, supporting neuronal recovery from insults through regenerative mechanisms.

Source: peptideinitiative.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →